EPOCAL RECEIVES FDA APPROVAL TO MARKET THE EPOCTM BLOOD ANALYSIS SYSTEM

Epocal is pleased to announce receipt of 510(k) clearance from the US Food and Drug Administration to market its first product -- the EPOCTM Enterprise Point of Care Blood Analysis System -- in the United States.

PRNewswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/10-11-2006/0004449863&EDATE)